A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

Retrospective Cohort Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

This study will examine the influence of the basal insulins detemir and glargine on risk of cardiovascular death and death from all causes in patients treated by their general practitioner in United Kingdom (UK). The data for this study will be drawn from the Clinical Practice Research Datalink (CPRD) Register.

Inclusion Criteria:

• Diagnosis (ever) of type 2 diabetes
• Prescription (ever) of basal insulins glargine or detemir
• Insulin-naïve until initiation of basal insulins glargine or detemir
• Aged 40 years or older at start of observation period

Exclusion Criteria:

• Diagnosis of type 1 diabetes